Treatment and Survivorship Interventions to Prevent Poor Body Image Outcomes in Breast Cancer Survivors

References

• SEER*Explorer: an interactive website for SEER cancer statistics. Surveillance Research Program, National Cancer Institute. Available from:https://seer.cancer.gov/explorer/. Accessed September15, 2021.
   Google Scholar
• American Cancer Society. Cancer Facts & Figures 2021. Atlanta: American Cancer Society; 2021. Available from:https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf. Accessed September15, 2021.
   Google Scholar
• Falk DahlCA, ReinertsenKV, NesvoldIL, FossåSD, DahlAA. A study of body image in long-term breast cancer survivors. Cancer. 2010;116(15):3549–3557. doi:10.1002/cncr.2525120564138
   PubMed Web of Science ®Google Scholar
• BonifaceJ, SzulkinR, JohanssonA. Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: a Swedish National 6-Year Follow-up of 48986 Women. JAMA Surg. 2021;156(7):628–637. doi:10.1001/jamasurg.2021.143833950173
   PubMed Web of Science ®Google Scholar
• BreninDR, DietzJR, BaimaJ, et al. Pain Management in Breast Surgery: recommendations of a Multidisciplinary Expert Panel-The American Society of Breast Surgeons. Ann Surg Oncol. 2020;27(12):4588–4602. doi:10.1245/s10434-020-08892-x32783121
   PubMed Web of Science ®Google Scholar
• FaguetGB. A brief history of cancer: age-old milestones underlying our current knowledge database. Int J Cancer. 2015;136(9):2022–2036. doi:10.1002/ijc.2913425113657
   PubMed Web of Science ®Google Scholar
• PlescaM, BordeaC, El HoucheimiB, IchimE, BlidaruA. Evolution of radical mastectomy for breast cancer. J Med Life. 2016;9(2):183–186.27453752
   PubMedGoogle Scholar
• FisherB. United States trials of conservative surgery. World J Surg. 1977;1:327–330. doi:10.1007/BF01556850883332
   PubMedGoogle Scholar
• CarlsonGW. Skin sparing mastectomy: anatomic and technical considerations. Am Surg. 1996;62:151–155.8554192
   PubMed Web of Science ®Google Scholar
• GerberB, KrauseA, ReimerT, et al. Skin-sparing mastectomy with conservation of the nipple-areola complex and autologous reconstruction is an oncologically safe procedure. Ann Surg. 2003;238(1):120–127. doi:10.1097/01.SLA.0000077922.38307.cd12832974
   PubMed Web of Science ®Google Scholar
• RomanoffA, ZaborEC, StempelM, SacchiniV, PusicA, MorrowM. A comparison of patient-reported outcomes after nipple-sparing mastectomy and conventional mastectomy with reconstruction. Ann Surg Oncol. 2018;25(10):2909–2916. doi:10.1245/s10434-018-6585-429968023
   PubMed Web of Science ®Google Scholar
• BoberSL, VarelaVS. Sexuality in adult cancer survivors: challenges and intervention. J Clin Oncol. 2012;30:3712–3719. doi:10.1200/JCO.2012.41.791523008322
   PubMed Web of Science ®Google Scholar
• FisherB, AndersonS, BryantJ, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–1241. doi:10.1056/NEJMoa02215212393820
   PubMed Web of Science ®Google Scholar
• De BonifaceJ, SzulkinR, JohanssonALV. Survival After Breast Conservation vs Mastectomy Adjusted for Comorbidity and Socioeconomic Status: a Swedish National 6-Year Follow-up of 48 986 Women. JAMA Surg. 2021;156(7):628–637.33950173
   PubMed Web of Science ®Google Scholar
• LagendijkM, van EgdomLSE, van VeenFEE, et al. Patient-reported outcome measures may add value in breast cancer surgery. Ann Surg Oncol. 2018;25(12):3563–3571. doi:10.1245/s10434-018-6729-630178391
   PubMed Web of Science ®Google Scholar
• KuererHM. Breast Surgical Oncology. 1st ed. New York: McGraw-Hill; 2010.
   Google Scholar
• KopkashK, ClarkP. Basic Oncoplastic Surgery for Breast Conservation: tips and Techniques. Ann Surg Oncol. 2018;25(10):2823–2828. doi:10.1245/s10434-018-6604-529968024
   PubMed Web of Science ®Google Scholar
• GainerSM, LucciA. Oncoplastics: techniques for reconstruction of partial breast defects based on tumor location. J Surg Oncol. 2011;103(4):341–347. doi:10.1002/jso.2167221337569
   PubMed Web of Science ®Google Scholar
• DeigniOA, BaumannDP, AdamsonKA, et al. Immediate Contralateral Mastopexy/Breast Reduction for Symmetry Can Be Performed Safely in Oncoplastic Breast-Conserving Surgery. Plast Reconstr Surg. 2020;145(5):1134–1142. doi:10.1097/PRS.000000000000672232332525
   PubMed Web of Science ®Google Scholar
• NguyenTT, HoskinTL, HabermannEB, ChevilleAL, BougheyJC. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol. 2017;24(10):2972–2980. doi:10.1245/s10434-017-5960-x28766228
   PubMed Web of Science ®Google Scholar
• KimT, GiulianoAE, LymanGH. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a meta-analysis. Cancer. 2006;106:4–16. doi:10.1002/cncr.2156816329134
   PubMed Web of Science ®Google Scholar
• BougheyJC, SumanVJ, MittendorfEA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310(14):1455–1461. doi:10.1001/jama.2013.27893224101169
   PubMed Web of Science ®Google Scholar
• KuehnT, BauerfeindI, FehmT, et al. Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 2013;14(7):609–618. doi:10.1016/S1470-2045(13)70166-923683750
   PubMed Web of Science ®Google Scholar
• HughesKS, SchnaperLA, BellonJR, et al. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382–2387. doi:10.1200/JCO.2012.45.261523690420
   PubMed Web of Science ®Google Scholar
• KunklerIH, WilliamsLJ, JackWJ, CameronDA, DixonJM. PRIME II investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015;16(3):266–273. doi:10.1016/S1470-2045(14)71221-525637340
   PubMed Web of Science ®Google Scholar
• BarnettGC, WilkinsonJS, MoodyAM, et al. The Cambridge Breast Intensity-modulated Radiotherapy Trial: patient- and treatment-related factors that influence late toxicity. Clin Oncol. 2011;23:662–673. doi:10.1016/j.clon.2011.04.011
   PubMed Web of Science ®Google Scholar
• MukeshMB, BarnettG, CummingJ, et al. Association of breast tumour bed seroma with postoperative complications and late normal tissue toxicity: results from the Cambridge Breast IMRT trial. Eur J Surg Oncol. 2012;38:918–924. doi:10.1016/j.ejso.2012.05.00822704052
   PubMed Web of Science ®Google Scholar
• LiviL, MeattiniI, MarrazzoL, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy versus whole breast irradiation: 5-year survival analysis of a Phase 3 randomised controlled trial. Eur J Cancer. 2015;51:451–463. doi:10.1016/j.ejca.2014.12.01325605582
   PubMed Web of Science ®Google Scholar
• MeattiniI, SaievaC, MarrazzoL, et al. Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial. Breast Cancer Res Treat. 2015;153:539–547. doi:10.1007/s10549-015-3565-226350524
   PubMed Web of Science ®Google Scholar
• CorbinK, MutterR. Proton therapy for breast cancer: progress & pitfalls. Breast Cancer Management. 2018;7(1):1758–1931. doi:10.2217/bmt-2018-0001
   Web of Science ®Google Scholar
• SparanoJA, GrayRJ, MakowerDF, et al. Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer. N Engl J Med. 2018;379(2):111. doi:10.1056/NEJMoa180471029860917
   PubMed Web of Science ®Google Scholar
• KalinskyK, BarlowWE, Meric-BernstamF, et al. First results from a Phase III randomized clinical trial of standard adjuvant endocrine therapy ± chemotherapy in patients with 1–3 positive nodes, hormone receptor-positive and HER2-negative breast cancer with recurrence score<25: SWOG S1007 (RxPonder). Cancer Res. 2020;81S:SABCS #GS3.
   Google Scholar
• NangiaJ, WangT, OsborneC, et al. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: the SCALP Randomized Clinical Trial. JAMA. 2017;317(6):596–605. doi:10.1001/jama.2016.2093928196254
   PubMed Web of Science ®Google Scholar
• MillerKD, SigelRL, LinCC, et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin. 2016;66:271–289. doi:10.3322/caac.2134927253694
   PubMed Web of Science ®Google Scholar
• AshikagaT, KragDN, LandSR, et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol. 2010;102(2):111–118. doi:10.1002/jso.2153520648579
   PubMed Web of Science ®Google Scholar
• JohnsonAR, SinghalD. Immediate lymphatic reconstruction. J Surg Oncol. 2018;118(5):750–757. doi:10.1002/jso.2517730114329
   PubMed Web of Science ®Google Scholar
• BoccardoF, CasabonaF, De CianF, et al. Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol. 2009;16(3):703–708. doi:10.1245/s10434-008-0270-y19139964
   PubMed Web of Science ®Google Scholar
• SchaverienMV, BadashI, PatelKM, SelberJC, ChengMH. Vascularized Lymph Node Transfer for Lymphedema. Semin Plast Surg. 2018;32(1):28–35. doi:10.1055/s-0038-163240129636651
   PubMed Web of Science ®Google Scholar
• ThomsonZO, ReevesMM. Can weight gain be prevented in women receiving treatment for breast cancer? A systematic review of intervention studies. Obes Rev. 2017;18(11):1364–1373. doi:10.1111/obr.1259128875575
   PubMed Web of Science ®Google Scholar
• RojasKE, MatthewsN, RakerC, et al. Body mass index (BMI), postoperative appearance satisfaction, and sexual function in breast cancer survivorship. J Cancer Surviv. 2018;12:127–133. doi:10.1007/s11764-017-0651-y29043480
   PubMed Web of Science ®Google Scholar
• EwertzM, JensenMB, GunnarsdottirKA, et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol. 2011;29:25–31. doi:10.1200/JCO.2010.29.761421115856
   PubMed Web of Science ®Google Scholar
• CampbellKL, Winters-StoneKM, WiskemannJ, et al. Exercise Guidelines for Cancer Survivors: consensus Statement from International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019;51(11):2375–2390. doi:10.1249/MSS.000000000000211631626055
   PubMed Web of Science ®Google Scholar
• SilverJK, BaimaJ. Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil. 2013;92(8):715–727. doi:10.1097/PHM.0b013e31829b4afe23756434
   PubMed Web of Science ®Google Scholar
• Santa MinaD, BrahmbhattP, LopezC, et al. The Case for Prehabilitation Prior to Breast Cancer Treatment. PM & R: The Journal of Injury, Function, and Rehabilitation. 2017;9(9S2):S305–S316. doi:10.1016/j.pmrj.2017.08.402
   Google Scholar
• WondersKY, HydockDS, SchneiderCM, HaywardR. Acute exercise protects against doxorubicin cardiotoxicity. Integr Cancer Ther. 2008;7(3):147–154. doi:10.1177/153473540832284818815146
   PubMed Web of Science ®Google Scholar
• CarliF, SilverJK, FeldmanLS, et al. Surgical Prehabilitation in Patients with Cancer: state-of-the-Science and Recommendations for Future Research from a Panel of Subject Matter Experts. Phys Med Rehabil Clin N Am. 2017;28(1):49–64. doi:10.1016/j.pmr.2016.09.00227913000
   PubMed Web of Science ®Google Scholar
• MolenaarCJL, Papen-BotterhuisNE, HerrleF, SlooterGD. Prehabilitation, making patients fit for surgery - a new frontier in perioperative care. Innov Surg Sci. 2019;4(4):132–138. doi:10.1515/iss-2019-001733977122
   PubMedGoogle Scholar
• YangA, SokolofJ, GulatiA. The effect of preoperative exercise on upper extremity recovery following breast cancer surgery: a systematic review. Int J Rehabil Res. 2018;41(3):189–196. doi:10.1097/MRR.000000000000028829683834
   PubMed Web of Science ®Google Scholar
• SebriV, DurosiniI, TribertiS, PravettoniG. The Efficacy of Psychological Intervention on Body Image in Breast Cancer Patients and Survivors: a Systematic-Review and Meta-Analysis. Front Psychol. 2021;12:611954. doi:10.3389/fpsyg.2021.61195433732184
   PubMed Web of Science ®Google Scholar
• FrancisPA, PaganiO, FlemingGF, et al. Tailoring adjuvant endocrine therapy for premenopausal breast cancer. N Engl J Med. 2018;379(2):122–137. doi:10.1056/NEJMoa180316429863451
   PubMed Web of Science ®Google Scholar
• LambertiniM, MooreHCF, LeonardRCF, et al. Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: a Systematic Review and Meta-Analysis of Individual Patient-Level Data. J Clin Oncol. 2018;36(19):1981–1990. doi:10.1200/JCO.2018.78.085829718793
   PubMed Web of Science ®Google Scholar
• GossPE, IngleJN, PritchardKI, et al. Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years. N Engl J Med. 2016;375(3):209–219. doi:10.1056/NEJMoa160470027264120
   PubMed Web of Science ®Google Scholar
• Leon-FerreRA, NovotnyPJ, WolfeEG, et al. Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: a Randomized, Double-Blind Clinical Trial (ACCRU SC-1603). JNCI Cancer Spectr. 2019;4(1):pkz088. doi:10.1093/jncics/pkz08832337497
   PubMed Web of Science ®Google Scholar
• KadakiaKC, HenryNL. Adjuvant endocrine therapy in premenopausal women with breast cancer. Clin Adv Hematol Oncol. 2015;13(10):663–672.27058571
   PubMedGoogle Scholar
• PartridgeAH, LaFountainA, MayerE, TaylorBS, WinerE, Asnis-AlibozekA. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol. 2008;26(4):556–562. doi:10.1200/JCO.2007.11.545118180462
   PubMed Web of Science ®Google Scholar
• HadjiP. Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy. Crit Rev Oncol Hematol. 2010;73(2):156–166. doi:10.1016/j.critrevonc.2009.02.00119299162
   PubMed Web of Science ®Google Scholar
• RunowiczCD, LeachCR, HenryNL, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66(1):43–73.26641959
   PubMed Web of Science ®Google Scholar
• BlancoC, MarkowitzJC, HershmanDL, et al. Study of Interpersonal Psychotherapy for Depressed Women with Breast Cancer. Am J Psychother. 2014;68(4):489–495.26453348
   PubMedGoogle Scholar
• SebriV, SavioniL, TribertiS, MazzoccoK, PravettoniG. How to Train Your Health: sports as a Resource to Improve Cognitive Abilities in Cancer Patients. Front Psychol. 2019;10:2096. doi:10.3389/fpsyg.2019.0209631572274
   PubMed Web of Science ®Google Scholar
• FingeretMC, TeoI, EpnerDE. Managing body image difficulties of adult cancer patients: lessons from available research. Cancer. 2014;120(5):633–641. doi:10.1002/cncr.28469
   PubMed Web of Science ®Google Scholar
• KalaitziC, PapadopoulosVP, MichasK, VlasisK, SkandalakisP, FilippouD. Combined brief psychosexual intervention after mastectomy: effects on sexuality, body image, and psychological well-being. J Surg Oncol. 2007;96(3):235–240. doi:10.1002/jso.2081117443731
   PubMed Web of Science ®Google Scholar
• de MoorJS, MariottoAB, ParryC, et al. Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomarkers Prev. 2013;22(4):561–570. doi:10.1158/1055-9965.EPI-12-135623535024
   PubMed Web of Science ®Google Scholar
• CarreiraH, WilliamsR, MüllerM, HarewoodR, StanwayS, BhaskaranK. Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: a Systematic Review. J Natl Cancer Inst. 2018;110(12):1311–1327. doi:10.1093/jnci/djy17730403799
   PubMedGoogle Scholar